504 related articles for article (PubMed ID: 19931264)
1. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
[TBL] [Abstract][Full Text] [Related]
2. The role of iron in nonalcoholic fatty liver disease: the story continues.
Kowdley KV
Gastroenterology; 2010 Mar; 138(3):817-9. PubMed ID: 20116466
[No Abstract] [Full Text] [Related]
3. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
[TBL] [Abstract][Full Text] [Related]
4. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
Bugianesi E; Manzini P; D'Antico S; Vanni E; Longo F; Leone N; Massarenti P; Piga A; Marchesini G; Rizzetto M
Hepatology; 2004 Jan; 39(1):179-87. PubMed ID: 14752836
[TBL] [Abstract][Full Text] [Related]
5. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
[TBL] [Abstract][Full Text] [Related]
6. Iron overload and HFE gene mutations in Polish patients with liver cirrhosis.
Sikorska K; Romanowski T; Stalke P; Iżycka-Świeszewska E; Bielawski KP
Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):270-5. PubMed ID: 21669570
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C, iron status, and disease severity: relationship with HFE mutations.
Tung BY; Emond MJ; Bronner MP; Raaka SD; Cotler SJ; Kowdley KV
Gastroenterology; 2003 Feb; 124(2):318-26. PubMed ID: 12557137
[TBL] [Abstract][Full Text] [Related]
8. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
[TBL] [Abstract][Full Text] [Related]
9. Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease.
Valenti L; Canavesi E; Galmozzi E; Dongiovanni P; Rametta R; Maggioni P; Maggioni M; Fracanzani AL; Fargion S
J Hepatol; 2010 Nov; 53(5):927-33. PubMed ID: 20739079
[TBL] [Abstract][Full Text] [Related]
10. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.
Cheng R; Barton JC; Morrison ED; Phatak PD; Krawitt EL; Gordon SC; Kowdley KV
J Clin Gastroenterol; 2009 Jul; 43(6):569-73. PubMed ID: 19359997
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease and HFE gene mutations: a Polish study.
Raszeja-Wyszomirska J; Kurzawski G; Lawniczak M; Miezynska-Kurtycz J; Lubinski J
World J Gastroenterol; 2010 May; 16(20):2531-6. PubMed ID: 20503453
[TBL] [Abstract][Full Text] [Related]
12. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.
Erhardt A; Maschner-Olberg A; Mellenthin C; Kappert G; Adams O; Donner A; Willers R; Niederau C; Häussinger D
J Hepatol; 2003 Mar; 38(3):335-42. PubMed ID: 12586300
[TBL] [Abstract][Full Text] [Related]
13. HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence.
Hellerbrand C; Pöppl A; Hartmann A; Schölmerich J; Lock G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):279-84. PubMed ID: 15017669
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of the hemochromatosis gene mutation in patients with nonalcoholic steatohepatitis and correlation with degree of liver fibrosis.
Zamin I; Mattos AA; Mattos AZ; Migon E; Bica C; Alexandre CO
Arq Gastroenterol; 2006; 43(3):224-8. PubMed ID: 17160239
[TBL] [Abstract][Full Text] [Related]
15. Role of liver biopsy in the diagnosis of hepatic iron overload in the era of genetic testing.
Nash S; Marconi S; Sikorska K; Naeem R; Nash G
Am J Clin Pathol; 2002 Jul; 118(1):73-81. PubMed ID: 12109859
[TBL] [Abstract][Full Text] [Related]
16. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
[TBL] [Abstract][Full Text] [Related]
17. Steatosis is a cofactor in liver injury in hemochromatosis.
Powell EE; Ali A; Clouston AD; Dixon JL; Lincoln DJ; Purdie DM; Fletcher LM; Powell LW; Jonsson JR
Gastroenterology; 2005 Dec; 129(6):1937-43. PubMed ID: 16344062
[TBL] [Abstract][Full Text] [Related]
18. Altered lipid metabolism in Hfe-knockout mice promotes severe NAFLD and early fibrosis.
Tan TC; Crawford DH; Jaskowski LA; Murphy TM; Heritage ML; Subramaniam VN; Clouston AD; Anderson GJ; Fletcher LM
Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G865-76. PubMed ID: 21817060
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan.
Lin TJ; Lin CL; Wang CS; Liu SO; Liao LY
World J Gastroenterol; 2005 Jul; 11(25):3905-8. PubMed ID: 15991291
[TBL] [Abstract][Full Text] [Related]
20. Heterozygous beta-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C.
Sartori M; Andorno S; Pagliarulo M; Rigamonti C; Bozzola C; Pergolini P; Rolla R; Suno A; Boldorini R; Bellomo G; Albano E
Gut; 2007 May; 56(5):693-8. PubMed ID: 17135308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
